EquityZen Growth Technology Fund LLC - Series 261
Raised
$150K
Investors
6
Min Invest
$20,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 261 is a Delaware-organized pooled investment vehicle filed June 27, 2018, raising $150K from 6 investors with a $20K minimum investment under Rule 506(b) and Section 3(c)(1). The entity is part of the EquityZen platform, which operates nearly 1,900 related series vehicles focused on pre-IPO secondary market investments.
This Series 261 vehicle represents a typical mid-2018 EquityZen single-deal SPV structure in the pre-IPO secondary category. The $20K minimum and 506(b) private placement exemption combined with 3(c)(1) status are standard for platforms enabling accredited investor access to shares of private growth-stage companies. The raise size and investor count align with deal-specific syndication rather than broadly marketed pooled funds.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.